Biovie (BIVI) Current Leases (2022 - 2026)
Biovie (BIVI) posted Current Leases of $82398.0 for Q1 2026, little changed sequentially from $82398.0 in Q4 2025, and up 16.52% YoY from $70713.0 in Q1 2025.
Biovie (BIVI) Current Leases (2022 - 2026) Analysis & Trends
Biovie has reported Current Leases for 5 years, with the latest figure at $82398.0 in Q1 2026.
- Quarterly Current Leases rose 16.52% year-over-year to $82398.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82398.0 (up 16.52% YoY) and the FY2025 annual result came in at $74464.0, up 23.4% from the prior year.
- Current Leases was little changed at $82398.0 in Q1 2026 per BIVI's latest filing, from $82398.0 in the prior quarter.
- Over five years, Current Leases peaked at $82398.0 in Q4 2025 and troughed at $29250.0 in Q1 2022.
- A 5-year average of $57048.9 and a median of $57143.0 in 2024 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 48.08% in 2023, down 15.42% in 2023.
- Over 5 years, Current Leases stood at $41788.0 in 2022, then grew by 15.42% to $48231.0 in 2023, then surged by 39.14% to $67111.0 in 2024, then climbed by 22.78% to $82398.0 in 2025, then changed by 0.0% to $82398.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $82398.0, $82398.0, and $78357.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Biovie | 13.61 Mn | 13.61 Mn | - | 91,009.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 91,009.00 |
| Mar 31, 2026 | 82,398.00 |
| Dec 31, 2025 | 82,398.00 |
| Sep 30, 2025 | 78,357.00 |
| Jun 30, 2025 | 74,464.00 |
| Mar 31, 2025 | 70,713.00 |
| Dec 31, 2024 | 67,111.00 |
| Sep 30, 2024 | 63,664.00 |
| Jun 30, 2024 | 60,343.00 |
| Mar 31, 2024 | 57,143.00 |
| Dec 31, 2023 | 48,231.00 |
| Sep 30, 2023 | 46,548.00 |
| Jun 30, 2023 | 44,909.00 |
| Mar 31, 2023 | 43,314.00 |
| Dec 31, 2022 | 41,788.00 |
| Sep 30, 2022 | 40,317.00 |
| Jun 30, 2022 | 38,884.00 |
| Mar 31, 2022 | 29,250.00 |